Financials

News Ideas Discussions Technicals Forecast Seasonals

S3F0 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to SANTHERA PHARMA operating, investing, and financing activities

S3F0 free cash flow for H2 24 is -20.32 M CHF. For 2024, S3F0 free cash flow was -35.68 M CHF and operating cash flow was -35.53 M CHF.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CHF

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—